The effects of retinyl acetate on the biosynthesis of sulfated glycosaminoglycans in dermal and epidermal cells isolated from newborn mice was investigated. Three compartments were analysed for [35S]-glycosaminoglycans; the culture medium, the cellular matrix, and the cells. The individual levels of chondroitin 4-sulfate, dermatan sulfate and heparin and/or heparan sulfate in these compartments as a function of retinyl acetate was also analysed. The addition of retinyl acetate resulted in a dose dependent increase 35SO4 incorporation in the cellular and matrix compartments of the dermis in vitro. At the optimum concentration of 1.8 X 10(-6) M, this increase was 50%. The levels of35SO4 incorporated into medium glycosaminoglycans were relatively constant. There were also changes in the levels of the individual sulfated glycosaminoglycans. The glycosaminoglycan profile was modified differently in each of the three compartments analysed. In the epidermal cells, retinyl acetate at an optimum concentration of 1.8 X 10(-6) M resulted in a dose dependent increase in 35SO4 incorporation in the cellular, matrix and medium compartments. There was no apparent change in the glycosaminoglycan profile, with heparin and/or heparan sulfate being the major sulfated glycosaminoglycan.
No takes yet. Share an insight, caveat, or question.
Shapiro et al. (1978) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: